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Abstract
Angiotensin II (Ang II) causes nitric oxide synthase (NOS) to become a
source of superoxide (O2
) via a protein kinase C (PKC)-dependent process
in endothelial cells. Ang II stimulates both NO and O2
 production in thick
ascending limbs. We hypothesized that Ang II causes O2
 production by NOS
in thick ascending limbs via a PKC-dependent mechanism. NO production
was measured in isolated rat thick ascending limbs using DAF-FM, whereas
O2
 was measured in thick ascending limb suspensions using the lucigenin
assay. Consistent stimulation of NO was observed with 1 nmol/L Ang II
(P < 0.001; n = 9). This concentration of Ang II-stimulated O2
 production
by 50% (1.77  0.26 vs. 2.62  0.36 relative lights units (RLU)/s/lg protein;
P < 0.04; n = 5). In the presence of the NOS inhibitor L-NAME, Ang II-sti-
mulated O2
 decreased from 2.02  0.29 to 1.10  0.11 RLU/s/lg protein
(P < 0.01; n = 8). L-arginine alone did not change Ang II-stimulated O2

(2.34  0.22 vs. 2.29  0.29 RLU/s/lg protein; n = 5). In the presence of
Ang II plus the PKC a/b1 inhibitor G€o 6976, L-NAME had no effect on O2

production (0.78  0.23 vs. 0.62  0.11 RLU/s/lg protein; n = 7). In the
presence of Ang II plus apocynin, a NADPH oxidase inhibitor, L-NAME did
not change O2
 (0.59  0.04 vs. 0.61  90.08 RLU/s/lg protein; n = 5). We
conclude that: (1) Ang II causes NOS to produce O2
 in thick ascending
limbs via a PKC- and NADPH oxidase-dependent process; and (2) the effect
of Ang II is not due to limited substrate.
Introduction
The reactive oxygen species nitric oxide (NO) and super-
oxide (O2
) have opposing physiological effects in the
kidney. In the thick ascending limb of the loop of Henle,
a nephron segment that is important in salt, water and
acid/base homeostasis (Burg 1982; Greger 1985; Mount
2014), NO and O2
 regulate ion transport (Garvin and
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Ortiz 2003). NO promotes natriuresis and diuresis (Majid
et al. 1993; Eitle et al. 1998; Plato et al. 1999; Ortiz et al.
2004b), whereas O2
 enhances Na reabsorption (Zou
et al. 2001; Majid and Nishiyama 2002; Juncos and Gar-
vin 2005; Juncos et al. 2006; Silva et al. 2006) and water
retention. Imbalances between these two factors in the
kidney can lead to renal pathophysiological conditions
such as hypertension (Sedeek et al. 2003; Kopkan and
Majid 2005; Kopkan et al. 2007; Majid and Kopkan 2007;
Ramseyer et al. 2015) and progressive renal injury.
The thick ascending limb is one of the predominant
sources of O2
 in the kidney (Zou et al. 2001; Li et al.
2002). In this segment, most of the O2
 is generated by
NADPH oxidase 4 (Hong and Garvin 2012; Massey et al.
2012), a process involving several steps. Ultimately, an
electron from NADPH is transferred to the oxidase sub-
domain and then to molecular O2, reducing it to O2
.
Thick ascending limb NADPH oxidase activity is
enhanced by a number of stimuli including luminal flow
(Hong and Garvin 2012), ion delivery (Hong and Garvin
2007), and angiotensin II (Ang II) (Li et al. 2002). We
have previously shown that Ang II stimulates NADPH
oxidase-dependent O2
 production by binding to Ang II
type 1 (AT1) receptors and activating protein kinase C
(PKC) (Herrera et al. 2010). We have also shown that
once O2
 is generated, it can stimulate PKC activity and
exert physiological effects including increasing Na reab-
sorption by thick ascending limbs (Silva et al. 2006).
Although NADPH oxidase is the primary source of O2

after Ang II stimulation, short hairpin RNAs against and
inhibitors of NADPH oxidase only reduce Ang II-
enhanced O2
 by about 70% suggesting that other
sources are involved. Potential sources include NO syn-
thase (NOS), cyclooxygenase, and the mitochondria (Zou
et al. 2001; Li et al. 2002).
Thick ascending limbs express all three isoforms of
NOS (Mount and Power 2006). NO synthesis involves
several steps. Ultimately, electrons are transferred from
NADPH via FAD and FMN to the oxidase domain of
NOS, which contains a heme group. These electrons are
then passed from the enzyme to the substrate, L-arginine,
causing its reduction to L-citrulline and release of NO. If
substrate or cofactors are lacking, under some circum-
stances NOS can produce O2
 rather than NO because
the electrons are transferred to molecular O2 rather than
L-arginine (Andrew and Mayer 1999). The balance
between NO and O2
 production by NOS can be regu-
lated by phosphorylation by a number of kinases includ-
ing PKC (Forstermann et al. 1994; Fleming 2010; Herrera
and Garvin 2010; Forstermann and Sessa 2012; Ramseyer
et al. 2015). The NOS inhibitor L-NAME blocks both NO
and O2
 generation by NOS. Several stimuli can enhance
NOS activity in thick ascending limbs including Ang II
(Cabral et al. 2010, 2012; Herrera and Garvin 2010; Peng
et al. 2014).
Similar to thick ascending limbs, Ang II stimulates both
O2
 production by NADPH oxidase and NO production
by NOS in endothelial cells. Ang II also causes NOS to
produce O2
 (Mollnau et al. 2002; Oak and Cai 2007;
Lobysheva et al. 2011; Lee et al. 2013; Galougahi et al.
2014; Saura et al. 2014) in endothelial cells. Thus, we
hypothesized that Ang II induces O2
 production by
NOS in thick ascending limbs via a PKC- and NADPH
oxidase-dependent process.
Materials and Methods
Animals
All protocols in this study were approved by the Case
Western Reserve University and the Henry Ford Hospital
Institutional Animal Care and Use Committees. All exper-
iments were conducted in accordance with the National
Institutes of Health Guidelines for the Care and Use of
Laboratory Animals. Male Sprague–Dawley rats (Charles
River Breeding Laboratories, Kalamazoo, MI) were fed a
diet containing 0.22% Na+ and 1.1% K+ for at least
6 days prior to the experiments. For terminal surgery,
animals were anesthetized with ketamine (100 mg/kg bw
IP) and xylazine (20 mg/kg bw IP), and given 2 IU hep-
arin (IP). Animals were killed while still under anesthesia.
Drugs and buffers
Unless specified, all drugs and reagents were obtained
from Sigma-Aldrich (St Louis, MO). The cell-permeant
NO-selective fluorescent dye DAF-FM-diacetate was pur-
chased from Invitrogen (Grand Island, NY). Coomassie
Plus Protein Assay Reagent was obtained from Thermo-
Scientific (Rockford, IL).
HEPES-buffered physiological saline contained (in
mmol/L): 10 HEPES (4-(2-hydroxyethyl)-1-piperazi-
neethanesulfonic acid) (pH 7.5 at 22°C), 130 NaCl, 4
KCl, 2.5 NaH2PO4, 1.2 MgSO4, 5.5 glucose, 6.0 DL-ala-
nine, 2.0 Ca(lactate)2, and 1.0 Na3citrate. Osmolality was
adjusted to 300  5 mOsmol/L with mannitol.
Thick ascending limb isolation
Single medullary thick ascending limbs were isolated as
previously described (Cabral et al. 2010, 2012). Briefly,
animals weighing 120–150 g were anesthetized and the
abdominal cavity opened. The left kidney was bathed in
ice-cold 150 mmol/L NaCl, and then, immediately
removed and placed in HEPES-buffered physiological sal-
ine at 4°C. Coronal slices were cut and individual thick
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ascending limbs isolated from the outer medulla under a
stereomicroscope at 4–8°C. Tubules ranging from 0.5–
1.0 mm were transferred to a temperature-regulated
chamber and maintained at 37  1°C. The bath was
exchanged at 0.6 ml/min.
Thick ascending limb suspensions
Suspensions were prepared as described before (Gonzalez-
Vicente and Garvin 2013; Gonzalez-Vicente et al. 2014).
Briefly, kidneys were perfused retrograde via the abdomi-
nal aorta with cold HEPES-buffered physiological saline
containing 2 USP/ml heparin and 0.1% of Type 4 collage-
nase. Perfused kidneys were removed, coronal slices cut,
and outer medullary tissue dissected and minced. Minced
tissue was digested in 0.1% collagenase for 30 min at
37°C. During digestion, tissue was agitated and gassed
with 100% O2 every 5 min. The sample was then cen-
trifuged (100 9 g, 2 min, 4°C), and the resulting pellet of
tubules resuspended in fresh HEPES-buffered physiologi-
cal saline and stirred on ice for 30 min. After stirring, the
sample was filtered through a 250 lm nylon mesh, and
the filtered tubules were collected and rinsed at 4°C. This
preparation resulted in a 95% pure suspension of thick
ascending limbs.
NO production measurement
NO production was measured by fluorescence microscopy
as previously described (Ramseyer et al. 2015). Briefly,
manually dissected thick ascending limbs were transferred
to a temperature-controlled chamber (37  1°C) on the
stage of an inverted microscope and fixed in place using
glass pipettes for live cell microscopy (Diaphot TMJ,
Nikon, Japan). The bath contained 100 lmol/l L-arginine,
but tubules were not submitted to luminal flow. Under
these conditions, NO production is negligible (Ortiz et al.
2001, 2004a). Tubules were loaded with the NO-sensitive
fluorescent dye DAF-FM (2 lmol/L) for 15 min and then
washed with physiological saline for 5 min. For imaging,
a 40X oil immersion objective was used. The dye was
excited by a xenon arc lamp with a 488 nm band pass fil-
ter. The fluorescence emitted by the NO-bound dye
(>500 nm) was measured using Metafluor software
(Molecular Devices, Sunnyvale CA). Results were
expressed as arbitrary fluorescent units (AFU)/min.
Superoxide production measurement
O2
 production was measured with bis-N-methylacridi-
nium nitrate (lucigenin). Lucigenin is a validated
luminescent probe to measure O2
 (Skatchkov et al.
1999; Ohashi et al. 2015), and it has been used in our
laboratory before (Ortiz and Garvin 2002; Herrera et al.
2010; Silva and Garvin 2010; Massey et al. 2012). Briefly,
for each experiment, lucigenin (5 lmol/L final concentra-
tion) was added to each of two plastic tubes containing
800 ll of warm-oxygenated physiological saline and kept
in the dark at 37°C. Then, 200-ll aliquots of freshly pre-
pared thick ascending limb suspension containing 100 to
200 lg of protein were added to each tube. The control
tube was placed in a luminometer (FB12/Sirius; Zylux
Oak Ridge, TN) and basal luminescence recorded at 4.8
sec intervals for 10 min using the provided software.
Then, the O2
 scavenger 4,5-dihydroxy-1,3-benzenedisul-
fonic acid (Tiron) was added to a final concentration of
10 mmol/L, and measurements were continued for 5 min.
The average luminescence of the last 2 min following the
addition of Tiron was then subtracted from the steady-
state luminescence before Tiron. Tubules were recovered
by centrifugation, and luminescence normalized for pro-
tein content.
In the experiments using Ang II, it was added before
placing the tubes in the luminometer. In some experi-
ments, we used the lipid-dependent PKC activator phor-
bol 12-myristate 13-acetate (PMA) instead of Ang II,
which was also added before placing the tubes in the
luminometer. For each set of experiments, the order of
the control and treatment tubes was randomized.
For the experiments involving either L-arginine or L-
NAME, the chemical was added during the generation of
the suspensions. When G€o 6976 or apocynin was used, it
was added 3 min before the addition of Ang II.
Statistical analysis
Results are expressed as the arithmetic mean  the stan-
dard error of the mean. The Student t-tests was used to
compare means. The P-values were calculated using
two-tailed tests in all cases, and paired or unpaired test
were used where appropriate. P < 0.05 was considered
significant.
Results
To show that Ang II activates thick ascending limb NOS
and stimulates NO production, and to study which con-
centration of Ang II should be used in subsequent experi-
ments, we measured the effect of different concentrations
(1013, 1011, 109 mol/L) of Ang II on NO production
by isolated thick ascending limbs. We found that within
5 min, 109 mol/L Ang II consistently increased NO pro-
duction (P < 0.001; n = 9), while lower concentrations
gave a highly variable response (Fig. 1).
Next, we tested whether a 5-min treatment with
109 mol/L Ang II increased O2
 production in thick
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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ascending limb suspensions in the absence of general
NOS substrate L-arginine, to avoid any potential interfer-
ence from endogenously produced NO. We found that
within 5 minutes, 109 mol/L Ang II increased O2
 pro-
duction by about 50% from 1.77  0.26 to 2.62  0.36
relative light units (RLU)/s/lg protein (P < 0.04; n = 5;
Fig. 2). Given that 5-min treatments with 109 mol/L
Ang II are capable of stimulating both NO and O2
, we
used this timeframe and concentration in all other
experiments.
Ang II stimulates O2
 production by NOS in endothe-
lial cells (Lobysheva et al. 2011). Thus, we next evaluated
the contribution of NOS-derived O2
 by measuring Ang
II-induced O2
 in the presence and absence of the general
NOS inhibitor L-NAME (1 mmol/L). These experiments
were conducted in the absence of L-arginine to avoid
interference by NO. We found that Ang II-induced O2

production in tubules treated with vehicle was
2.02  0.29 RLU/s/lg protein, while in those treated with
L-NAME, it was 1.10  0.11 RLU/s/lg (P < 0.01; n = 8;
Fig. 3). Thus, blocking NOS reduces Ang II-stimulated
O2
 more than 40%.
The results presented in Figure 3 indicate that Ang II
stimulates O2
 production by NOS. This can be due to a
direct effect or due to lack of substrate, that is, L-argi-
nine. To test whether Ang II-stimulated NOS-dependent
O2
 production was a result of lack of L-arginine, we
repeated the experiments in the presence and absence of
100 lmol/L L-arginine. We found that Ang II-induced
O2
 production was not different in the presence
(2.34  0.22 RLU/s/lg protein) or absence (2.29  0.29
RLU/s/lg protein) of L-arginine (n = 5; Fig. 4). These
data indicate that Ang II-stimulated O2
 production by
NOS is not only a consequence of the lack of L-arginine
to accept electrons, and thus other effects may be
involved.
Previous reports indicate that PKC activation causes
NOS to produce O2
. Ang II can stimulate PKC activity in
thick ascending limbs both directly (Herrera et al. 2010)
and indirectly via O2
 (Silva et al. 2006; Herrera et al.
2010). Therefore, we next tested whether PKC activation
was required for Ang II to increase NOS-derived O2
, by
measuring Ang II-induced O2
 in the presence and
absence of L-NAME, while inhibiting PKCa/b1 with
100 nmol/L G€o 6976 (Fig. 5). We found that in the pres-
ence of Ang II and G€o 6976, O2
 production was unaltered
by L-NAME (0.78  0.23 vs. 0.62  0.11 RLU/s/lg pro-
tein; n = 7). These data indicate that PKC activation is
necessary for Ang II to stimulate O2
 production by NOS.
Ang II can also stimulate PKC indirectly by increasing
O2
 derived from NADPH oxidase (Silva et al. 2006;
Herrera et al. 2010). Apocynin reduces Ang II-stimulated
O2
 from NADPH oxidase (Herrera et al. 2010). There-
fore, to test whether NADPH oxidase was involved in the
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Figure 1. Effect of acute angiotensin II (Ang II) treatment on NO
production by isolated thick ascending limbs. Tubules were
manually dissected, held with pipettes and NO production
measured with DAF-FM. P < 0.001 versus basal; n = 9 for 1 nmol/L
Ang II. AFU, arbitrary fluorescence units.
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Figure 2. Effect of 1 nmol/L Ang II on O2
 production by thick
ascending limb suspensions (P < 0.04; n = 5). Lucigenin plus Tiron
were used to detect O2
 production in the presence or absence of
Ang II.
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Figure 3. Effect of the NOS inhibitor L-NAME (1 mmol/L) on Ang
II-induced O2
 in thick ascending limb suspensions (P < 0.01;
n = 8). Lucigenin plus Tiron were used to detect Ang II-stimulated
O2
.
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ability of Ang II to stimulate O2
 by NOS, we measured
Ang II-induced O2
 in the presence and absence of L-
NAME, when NADPH oxidase was blocked with
10 lmol/L apocyinin (Fig. 6). We found that in the pres-
ence of Ang II and apocynin, O2
 production was not
affected by L-NAME (0.59  0.04 vs. 0.61  0.08 RLU/s/
lg protein; n = 5). These data indicate that NADPH oxi-
dase activation is a necessary event for Ang II to increase
O2
 production by NOS in thick ascending limbs.
Finally, to test whether direct activation of lipid-depen-
dent PKC isoforms was able to stimulate O2
 production
by NOS in our system, we measured the effect of PMA
alone on O2
 production, and the effect of L-NAME on
PMA-stimulated O2
 production in the presence of
apocynin. We found that PMA-stimulated O2
 produc-
tion from 1.5  0.3 to 12.8  2.8 RLU/s/lg protein
(P < 0.05, n = 5). L-NAME reduced PMA-stimulated
O2
 production in the presence of apocynin by
49  15% (P < 0.05, n = 4). These data indicate that
lipid-dependent PKC isoform activation increases O2

production by NOS in the absence of NADPH oxidase-
derived O2
 in thick ascending limbs.
Discussion
We hypothesized that Ang II causes NOS to become a
source of O2
 and that this effect is dependent on PKC
and NADPH oxidase. This implies that Ang II stimulates
both O2
 and NO production. Therefore, we began our
study by directly measuring the effect of different concen-
trations of Ang II on NO production by rat thick ascend-
ing limbs. We found that 1 nmol/L Ang II stimulates
thick ascending limb NO production within 5 minutes.
Using this concentration of Ang II, we next tested
whether it also stimulates O2
 production. We found that
1 nmol/L Ang II stimulated O2
 by approximately 50%
in the same time frame as it stimulates NO. Taken
together, these data suggest that there is a concomitant
production of NO and O2
 upon Ang II stimulation in
the thick ascending limbs. The O2
 experiments were per-
formed in the absence of L-arginine, the substrate for
NOS, because NO and O2
 can react to form peroxyni-
trite if they are generated in the same compartment at the
same time (Pryor and Squadrito 1995; Squadrito and
Pryor 1995) and we have shown that NO can inhibit O2

production via a cGMP-dependent mechanism. The
results showing that Ang II stimulates both NO and O2

in the same time frame are consistent with our previous
studies in which we found that Ang II stimulates NO
(Herrera and Garvin 2010) and O2
 (Herrera et al. 2010;
Massey et al. 2012). They are also consistent with findings
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Figure 4. Effect of the NOS substrate L-arginine (100 lmol/L) on
Ang II-induced O2
 in thick ascending limb suspensions (n = 5).
Lucigenin plus Tiron were used to detect Ang II-stimulated O2
.
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Figure 5. : Effect of the NOS inhibitor L-NAME (1 mmol/L) on Ang
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 in thick ascending limb suspensions in the
presence of the PKCa/b1 inhibitor G€o 6976 (100 nmol/L)(n = 7).
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Figure 6. Effect of the NOS inhibitor L-NAME (1 mmol/L) on Ang
II-stimulated O2
 in thick ascending limb suspensions in the
presence of the NADPH oxidase inhibitor apocynin (10 lmol/L)
(n = 5). Lucigenin plus Tiron were used to detect Ang II-stimulated
O2
.
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of other investigators (Mori and Cowley 2003; Lobysheva
et al. 2011).
Although it is generally accepted that Ang II stimulates
O2
 in the thick ascending limb primarily by NADPH
oxidase, this enzyme is not the only source of Ang II-sti-
mulated O2
 in this nephron segment. We and others
have shown that other sources account for 10 (Mori and
Cowley 2003; Herrera et al. 2010) to 40% (Massey et al.
2012) of the O2
 produced by thick ascending limbs
upon Ang II stimulation. However, in the previous stud-
ies, the identity of such sources was not determined.
Therefore, we next investigated the contribution of NOS
to the increase in O2
 production caused by Ang II by
studying whether L-NAME, a NOS inhibitor, alters the
ability of Ang II to enhance O2
 production. We found
that blocking NOS reduced Ang II-stimulated O2
 by
40%. These data suggest that Ang II stimulates NOS to
produce O2
.
Our results showing that Ang II causes NOS to pro-
duce O2
 are similar to reports in other cell types (Loby-
sheva et al. 2011; Lee et al. 2013; Galougahi et al. 2014;
Kossmann et al. 2014; Saura et al. 2014). NOS has been
shown to be a source of O2
 after Ang II treatment in
endothelial cells (Lobysheva et al. 2011). Further support
of this concept comes from studies in Ang II-induced
hypertensive animals. For instance, NOS3 was upregulated
at both the RNA and protein levels in the myocardium
(Tambascia et al. 2001) and vessels (Mollnau et al. 2002;
Sullivan et al. 2002) of Ang II-treated rats as compared to
controls. However, these animals presented a marked
decrease in vascular NO bioavailability as well as endothe-
lial dysfunction, which is associated with elevated O2
.
Thus, elevated NOS does not necessarily lead to an
increase in NO, and NOS-derived O2
 may represent a
mechanism whereby Ang II causes prolonged oxidative
stress (Oak and Cai 2007).
An alternative explanation for our data could be that
Ang II-stimulated NO production is required to activate
O2
 production from another source such as xanthine oxi-
dase, cyclooxygenase, or the mitochondria. This seems
unlikely because neither xanthine oxidase nor cyclooxyge-
nase activities have been shown to be affected by NO or
cGMP. While mitochondrial respiration has been shown to
be regulated by NO, it reduces oxygen consumption by this
organelle rather than increasing it (Boveris et al. 2003).
In our experiments, we showed that Ang II causes NOS
to produce O2
 in the absence of exogenously added L-
arginine. Lack of substrate causes the active enzyme to
transfer electrons not to L-arginine but to molecular oxy-
gen thereby generating O2
. Thus, we tested whether Ang
II-stimulated O2
 was altered in the presence or absence
of L-arginine. We found that Ang II-induced O2
 pro-
duction was not significantly altered by L-arginine. These
data indicate that a simple lack of NOS substrate is not
the main mechanism mediating the increase in O2
 in
our experimental conditions.
Since NO inhibits O2
 production and that NO and
O2
 can react to form peroxynitrite in isolated perfused
tubules, one might ask why adding L-arginine to the sus-
pension media did not alter Ang II-stimulated O2
 pro-
duction via one of these pathways. The explanation is
that unlike the isolated, perfused tubule preparation,
where the bath is >106 times the volume of the tubule
and L-arginine is being washed out continuously, the
thick ascending limb suspensions are always in a
restricted space. This allows the tubules to retain enough
endogenous L-arginine to support NO production during
the experiment, given that the K½ for L-arginine is only
about 2 lmol/L, and at the time of isolation, the thick
ascending limb cells may contain as much as 300 lmol/L
L-arginine.
A similar consideration should be made for the cofac-
tor tetrahydrobiopterin (BH4). Even though reductions in
BH4 can cause O2
 production by NOS (Bec et al. 1998;
Andrew and Mayer 1999; Adak et al. 2000), this seems
unlikely in our experimental conditions. Addition of the
BH4 precursor sepiapterin to thick ascending limb sus-
pensions has no effect on NO production (Herrera et al.
2006). This indicates that BH4 is not a limiting factor in
our preparation. Thus, although BH4 levels are affected in
models of chronic hypertension (Landmesser et al. 2003),
including those dependent on Ang II (Kang et al. 2011),
there is no evidence that acute exposure to Ang II per se
reduces BH4 levels. Thus, reduced cofactors availability is
not likely the cause of NOS-derived O2
 in this case.
Because Ang II activates PKC both directly and indi-
rectly, and PKC activation can increase O2
 production
from NOS in other cells (Chen et al. 2014), we next
tested whether PKC was necessary for Ang II to increase
O2
 production from NOS in thick ascending limbs. We
found that when PKC was blocked, L-NAME had no
effect on Ang II-stimulated O2
. The importance of PKC
as a mediator of O2
 production is in agreement with
our previous studies in thick ascending limbs (Silva et al.
2006; Herrera et al. 2010; Hong et al. 2010). However,
this study is the first to identify a role in NOS-derived
O2
 production.
Ang II can indirectly activate PKC by stimulating
NADPH oxidase activity. To test whether NADPH oxi-
dase is required for Ang II to stimulate O2
 production
by NOS, we used apocynin. We found that apocynin pre-
vented Ang II from enhancing O2
 production by NOS.
These data indicate that NADPH oxidase activity is
required for Ang II’s effect on NOS.
When taken together with published studies, the cur-
rent PKC, apocynin, and PMA data suggest two possible
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pathways by which Ang II treatment can lead to O2
 pro-
duction by NOS. Ang II binds AT1 receptors which acti-
vate PKCa (Herrera et al. 2010). PKCa then increases
NADPH oxidase activity (Herrera et al. 2010; Hong et al.
2010; Massey et al. 2012). The O2
 thus produced either:
(1) further activates the same pool of PKCa which
increases NOS phosphorylation; or (2) activates a differ-
ent pool of PKCa/d (Silva et al. 2006). PKCa/d then
phosphorylates NOS causing it to produce O2
. There-
fore, according to this model, the PKCa directly activated
by Ang II does not cause NOS to produce O2
 because
either: (1) it is in a different cellular compartment than
the one that phosphorylates NOS; or (2) Ang II may sim-
ply not increase PKCa sufficiently to affect NOS. The
proposed model is represented in Figure 7.
Another open question that cannot yet be answered is
which NOS isoform is responsible from O2
 production
in response to Ang II; however, some conclusions can
be drawn based on published studies. First, NOS2 is
mainly regulated at the transcriptional level and its
abundance is at the limit of detection under nonstimu-
lating conditions in the rat kidney (Zhang et al. 2000;
Stumm et al. 2002), thereby making it unlikely to medi-
ate any effect in acute experiments. Second, NOS1 is
not phosphorylated by PKC (Okada 1996); PKC instead
affects its sensitivity for calcium indirectly (Okada 1995),
and exerts inhibitory rather than stimulatory effects
(Riccio et al. 1996). Thus, NOS1 is not a likely candi-
date either. Finally, NOS3 is directly phosphorylated by
PKC (Fleming et al. 2001; Chen et al. 2014) causing it
to produce O2
 (Lin et al. 2003; Chen et al. 2014).
Taking all this into account, our data suggest that NOS3
mediates NOS-derived O2
 in response to acute Ang II
stimulation. Studies with double knockouts that would
provide a definitive answer to this question are far out
of the scope of this paper.
In summary, we found that Ang II acutely causes O2

production by NOS in thick ascending limbs. This pro-
cess is dependent on PKC and NADPH oxidase and
remains present in excess of L-arginine. Stimulation of
NO and O2
 by such factors as Ang II is important in
regulating renal water and salt reabsorption. Understand-
ing the processes involved in maintaining the balance
between NO and O2
 may give insight into the pathogen-
esis and treatment of diseases associated with oxidative
stress and Na retention.
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